Operating Company Healthcare

THREAD

Cary, North Carolina, United States

THREAD provides a clinical research technology platform and scientific consulting services to help life sciences organizations design, operate, and scale decentralized clinical trials (DCT) and electronic clinical outcome assessments (eCOA) for participants, sites, and study teams.

Focus Areas
Decentralized clinical trials (DCT) technology, eCOA/ePRO programs, eConsent

Tracked deals

3

3 tracked deals across 2021-2022.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

2 buyout · 1 addon

THREAD Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for THREAD. 1 2021 2 2022

Supporting Data

Recent Transactions

  • April 19, 2022
    Buyer
    THREAD
    Target
    CureClick
    Type
    Buyout

    THREAD has acquired CureClick, a Costa Mesa-based crowdsourcing platform that accelerates awareness and participation in clinical research. The deal brings CureClick’s community of more than 6,500 ambassadors and a reach of over one million patients into THREAD’s decentralized clinical trials (DCT) platform; CureClick founder Fabio Gratton will join THREAD as chief experience officer.

  • Buyer
    THREAD
    Target
    inVibe
    Type
    Addon

    THREAD, a Cary, North Carolina-based decentralized clinical trials technology and service provider, has acquired inVibe, a voice-powered research and insights technology company focused on life sciences and healthcare. The deal integrates inVibe’s voice capture, NLP and linguist-led analysis into THREAD’s platform as an add-on capability to broaden patient-centered research, recruitment and real‑time insight offerings; financial terms were not disclosed.

  • Buyer
    THREAD
    Target
    Modus Outcomes
    Type
    Buyout

    THREAD has acquired Modus Outcomes to combine its decentralized clinical trial (DCT) technology platform with Modus' clinical outcomes consulting, psychometrics and biostatistics capabilities. The deal (financial terms not disclosed) expands THREAD's scientific capabilities and global footprint — adding Modus' offices in London and Lyon and a team of ~40 experts to THREAD's DCT offering.

Related Acquisition Pages

Selling a company? Get in front of buyers like THREAD

Turn tracked acquisition activity into an outreach-ready buyer list.